Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

ONCOIMMUNOLOGY

eISSN: 2162-402XpISSN: 2162-402X
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Oncology
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    TAYLOR & FRANCIS INC
  • Language
    English
  • Frequency
    Monthly
  • Article Processing Charges
    GBP 2495
  • Publication Time
    24
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 21%
4-6 57%
7-9 16%
>9 6%

Topics Covered

Cancer
Immunotherapy
Lung cancer
Overall survival
Melanoma
Electroporation
Antigen
Tumor growth
Progression-free survival
Plasma levels
Leiomyosarcoma
Myeloid cells
Immunization
Tumor microenvironment
Breast cancer
Disease progression
Antitumor immunity
Tumor-infiltrating lymphocytes
Lymph node
Immune checkpoint

Recently Published Papers

FAQs

Since when has ONCOIMMUNOLOGY been publishing? Faqs

The ONCOIMMUNOLOGY has been publishing since 2012 till date.

How frequently is the ONCOIMMUNOLOGY published? Faqs

ONCOIMMUNOLOGY is published Monthly.

Who is the publisher of ONCOIMMUNOLOGY? Faqs

The publisher of ONCOIMMUNOLOGY is TAYLOR & FRANCIS INC.

How can I view the journal metrics of ONCOIMMUNOLOGY on editage? Faqs

For the ONCOIMMUNOLOGY metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of ONCOIMMUNOLOGY? Faqs

The eISSN number is 2162-402X and pISSN number is 2162-402X for ONCOIMMUNOLOGY.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Immunotherapy, Lung cancer, Overall survival, Melanoma, Electroporation, Antigen, Tumor growth, Progression-free survival, Plasma levels, Leiomyosarcoma, Myeloid cells, Immunization, Tumor microenvironment, Breast cancer, Disease progression, Antitumor immunity, Tumor-infiltrating lymphocytes, Lymph node, Immune checkpoint.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.